
Magnolol reduces myocardial injury induced by renal ischemia and reperfusion
Author(s) -
ChingWen Tang,
Chang-Chi Lai,
PoHsun Huang,
An-Han Yang,
Shu Chiung Chiang,
Po-Chao Huang,
Kuo-Wei Tseng,
Ch-Hpin Huang
Publication year - 2022
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000727
Subject(s) - medicine , magnolol , lactate dehydrogenase , creatine kinase , magnolia officinalis , cardiology , ischemia , troponin i , renal function , ejection fraction , endocrinology , myocardial infarction , anesthesia , urology , pharmacology , pathology , heart failure , enzyme , biochemistry , chemistry , alternative medicine , traditional chinese medicine
Magnolol is a component of the bark of Magnolia officinalis, which is a traditional herbal remedy used in China. In this study, we investigated whether magnolol can reduce myocardial injury induced by renal ischemia and reperfusion (I/R).